To take a further step, we recently demonstrated a synergistic effect of the HDAC inhibitor SAHA on NIS expression induced by suppressing the MAP kinase and PI3K/Akt pathways in thyroid cancer cells although, in this study, histone acetylation was not examined [13]. Here, HDAC9 is linked to thyroid gland carcinoma.